[Intensive therapy in type 2 diabetes. More damage than benefit?]

MeSH terms

• Aged
• Biomarkers / blood
• Blood Glucose / metabolism*
• Cerebral Infarction / blood
• Cerebral Infarction / mortality
• Cerebral Infarction / prevention & control*
• Diabetes Mellitus, Type 2 / blood
• Diabetes Mellitus, Type 2 / drug therapy*
• Diabetes Mellitus, Type 2 / mortality
• Diabetic Angiopathies / blood
• Diabetic Angiopathies / mortality
• Diabetic Angiopathies / prevention & control
• Diabetic Nephropathies / blood
• Diabetic Nephropathies / mortality
• Diabetic Nephropathies / prevention & control
• Drug Therapy, Combination
• Female
• Glycated Hemoglobin / metabolism*
• Humans
• Hypoglycemic Agents / adverse effects
• Hypoglycemic Agents / therapeutic use
• Male
• Middle Aged
• Myocardial Infarction / blood
• Myocardial Infarction / mortality
• Myocardial Infarction / prevention & control*
• Randomized Controlled Trials as Topic
• Survival Rate